Biochips Market, By Product Type (DNA Chips, Protein Chips, Lab-on-chip Tissue Arrays, Cell Arrays), By End User (Biotechnology and Pharmaceutical Companies, Academic & Research Institutes, Hospitals and Diagnostic Centers, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Feb 2025

Code : CMI1146

Pages :152

Formats :

Excel and PDF

Industry : Biotechnology

Biochips Market Size and Trends

Global biochips market is estimated to be valued at USD 13.34 Bn in 2025 and is expected to reach USD 37.73 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 16.0% from 2025 to 2032.

Biochips Market Key Factors

To learn more about this report, Request sample copy

Increasing application of biochips in the field of proteomics, genomics and drug discovery can drive the market growth. Extensive R&D activities in the field of healthcare and growing demand for point-of-care testing and diagnostics can also boost demand for biochips during the forecast period. Advancements in microarray and microfluidic technologies can drive the global biochips market growth. Increasing government investments and funding for development of personalized medicine can drive the biochips market growth.

Increasing R&D Funding and Government Initiatives

Global biochips market growth is driven by increasing funding for life science research and development across both public and private sectors. Governments around the world recognize the profound potential of biochip technology to revolutionize healthcare diagnosis and treatment, unlock new opportunities in personalized medicine, and drive national innovation and economic growth. Thus, there has been increase in funding for research into novel biochip applications from both federal grants and public-private partnerships. Major economies like the U.S., China, Japan, Germany and India have all outlined ambitious strategic plans designating bioengineering and bio microsystems as national priorities. Alongside increased R&D funding, governments are incentivizing commercialization through tax holidays, reimbursement programs, and seed grants for startups. Rising international collaborations can also pool resources and accelerate the pace of development.